ADINA Act

This bill, known as the "ADINA Act," proposes changes to the Federal Food, Drug, and Cosmetic Act. It aims to require drugs intended for human use to include specific labeling information. Specifically, any drug containing an ingredient that is a major food allergen or derived from a gluten-containing grain must disclose this on its label. This includes identifying each such ingredient and, when applicable, the specific type of gluten-containing grain. The new rules would take effect within two years of enactment or on a date set by the Secretary of Health and Human Services.